PAPER Forester BP, Rahman AT, Harper DG, Petrides G
SEARCH RESULTS
16173 RESULTS
PAPER Agin-Liebes J, Cortes E, Vonsattel JP, Marder K, Alcalay RN
Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease.
Parkinsonism Relat Disord. 2019 Nov 9; PubMed: 31734038PAPER Riphagen JM, Ramakers IH, Freeze WM, Pagen LH, Hanseeuw BJ, Verbeek MM, Verhey FR, Jacobs HI
Linking APOE-ε4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology.
Neurobiol Aging. 2020 Jan;85:96-103. Epub 2019 Oct 15 PubMed: 31733942PAPER Hoffman JL, Faccidomo S, Kim M, Taylor SM, Agoglia AE, May AM, Smith EN, Wong LC, Hodge CW
Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.
Int Rev Neurobiol. 2019;148:169-230. Epub 2019 Oct 23 PubMed: 31733664PAPER Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou-Karistianis N
Brain compensation during visuospatial working memory in premanifest Huntington's disease.
Neuropsychologia. 2020 Jan;136:107262. Epub 2019 Nov 14 PubMed: 31734228PAPER Canas LS, Sudre CH, De Vita E, Nihat A, Mok TH, Slattery CF, Paterson RW, Foulkes AJ, Hyare H, Cardoso MJ, Thornton J, Schott JM, Barkhof F, Collinge J, Ourselin S, Mead S, Modat M
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.
Neuroimage Clin. 2019;24:102051. Epub 2019 Oct 25 PubMed: 31734530PAPER Hassani OK, Rymar VV, Nguyen KQ, Huo L, Cloutier JF, Miller FD, Sadikot AF
The noradrenergic system is necessary for survival of vulnerable midbrain dopaminergic neurons: implications for development and Parkinson's disease.
Neurobiol Aging. 2020 Jan;85:22-37. Epub 2019 Sep 30 PubMed: 31734438PAPER Giangrasso DM, Furlong TM, Keefe KA
Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.
Neurobiol Dis. 2020 Feb;134:104673. Epub 2019 Nov 15 PubMed: 31734455Weiqun Liu
Blade Therapeutics, IncSouth San Francisco, United States
Renzo Mancuso on Cell-Specific Enhancer Atlas Centers AD Risk in Microglia. Again.
COMMENT This is an extraordinary study that provides a final piece of evidence for the causal involvement of microglia in Alzheimer’s disease. This work follows up a previous report from the same group, where the authors performed transcriptomic analysis of human
Andrea Crotti
TakedaSan Diego, United States
Maureen McLennon
Ruth Itzhaki on China Approves Seaweed Sugar as First New Alzheimer’s Drug in 17 Years
COMMENT The intriguing and encouraging results of the GV971 trial could be explained by an alternative—or perhaps additional—mechanism: the protective effect against AD might well be the consequence of the drug acting as an antiviral agent against HSV1, which has
PAPER Naesens L, Bonnafous P, Agut H, De Clercq E
Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts.
J Clin Virol. 2006 Dec;37 Suppl 1:S69-75. PubMed: 17276373PAPER Harden EA, Falshaw R, Carnachan SM, Kern ER, Prichard MN
Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus.
Antiviral Res. 2009 Sep;83(3):282-9. Epub 2009 Jul 1 PubMed: 19576248Current Filters
- Date Range : Nov 2018 to Nov 2019 x